Protocol for initiation of miglustat treatment in NP-C. Reproduced

Distinct Niemann-Pick Disease Type C Clinical, Cytological, and Biochemical Phenotype in an Adult Patient With 1 Mutated, Overexpressed NPC1 Allele - Julia Jecel, Klaus Harzer, Eduard Paschke, Stefanie Beck-Wödl, Peter Bauer, Milos

Severely impaired CTL killing is a feature of the neurological disorder Niemann-Pick disease type C1 - ScienceDirect

IJMS, Free Full-Text

Protocol for initiation of miglustat treatment in NP-C. Reproduced with

Different Niemann-Pick C1 Genotypes Generate Protein Phenotypes that Vary in their Intracellular Processing, Trafficking and Localization

Tolerance of chronic HDACi treatment for neurological, visceral and lung Niemann-Pick Type C disease in mice

Full article: New therapies in the management of Niemann-Pick type C disease: clinical utility of miglustat

MRx Pipeline October by Magellan Rx Management - Issuu

Miglustat for treatment of Niemann-Pick C disease: a randomised controlled study - The Lancet Neurology

Loss of NPC1 enhances phagocytic uptake and impairs lipid trafficking in microglia

Frontiers Adult-Onset Niemann–Pick Disease Type C: Rapid Treatment Initiation Advised but Early Diagnosis Remains Difficult